These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 18955523

  • 21. Stool transplantation for older patients with Clostridium difficile infection.
    Rubin TA, Gessert CE, Aas J.
    J Am Geriatr Soc; 2009 Dec; 57(12):2386. PubMed ID: 20122011
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
    Miller M.
    Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
    [Abstract] [Full Text] [Related]

  • 25. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Bartlett JG.
    Clin Infect Dis; 2008 May 15; 46(10):1489-92. PubMed ID: 18419480
    [No Abstract] [Full Text] [Related]

  • 26. Alternative therapies for Clostridium difficile infections.
    Venuto C, Butler M, Ashley ED, Brown J.
    Pharmacotherapy; 2010 Dec 15; 30(12):1266-78. PubMed ID: 21114394
    [Abstract] [Full Text] [Related]

  • 27. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S.
    J Infect; 2009 Jun 15; 58(6):403-10. PubMed ID: 19394704
    [Abstract] [Full Text] [Related]

  • 28. Clostridium difficile infection: current perspectives.
    Janka J, O'Grady NP.
    Curr Opin Crit Care; 2009 Apr 15; 15(2):149-53. PubMed ID: 19578325
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents.
    Van Hise NW, Bryant AM, Hennessey EK, Crannage AJ, Khoury JA, Manian FA.
    Clin Infect Dis; 2016 Sep 01; 63(5):651-3. PubMed ID: 27318333
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [A case of slowly resolving enteritis caused by Clostridium difficile].
    Zoppi G, Vinco A, Cinquetti M, Barbato G, Luciano A.
    Pediatr Med Chir; 1995 Sep 01; 17(5):459-60. PubMed ID: 8685005
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of surotomycin in an in vitro gut model of Clostridium difficile infection.
    Chilton CH, Crowther GS, Todhunter SL, Nicholson S, Freeman J, Chesnel L, Wilcox MH.
    J Antimicrob Chemother; 2014 Sep 01; 69(9):2426-33. PubMed ID: 24816211
    [Abstract] [Full Text] [Related]

  • 33. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ, Wilcox MH.
    Clin Infect Dis; 2008 Jul 01; 47(1):63-5. PubMed ID: 18491959
    [No Abstract] [Full Text] [Related]

  • 34. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
    Venugopal AA, Johnson S.
    Clin Infect Dis; 2012 Feb 15; 54(4):568-74. PubMed ID: 22156854
    [Abstract] [Full Text] [Related]

  • 35. Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection.
    Sirbu BD, Soriano MM, Manzo C, Lum J, Gerding DN, Johnson S.
    Clin Infect Dis; 2017 Oct 15; 65(8):1396-1399. PubMed ID: 28591789
    [Abstract] [Full Text] [Related]

  • 36. Intracolonic administration of vancomycin for Clostridium difficile infection.
    Grimm M, Rafael T.
    Nursing; 2014 Sep 15; 44(9):58-60. PubMed ID: 25140945
    [No Abstract] [Full Text] [Related]

  • 37. Clostridium difficile infections: emerging epidemiology and new treatments.
    Cohen MB.
    J Pediatr Gastroenterol Nutr; 2009 Apr 15; 48 Suppl 2():S63-5. PubMed ID: 19300129
    [Abstract] [Full Text] [Related]

  • 38. Risk factors for systemic vancomycin exposure following administration of oral vancomycin for the treatment of Clostridium difficile infection.
    Pettit NN, DePestel DD, Fohl AL, Eyler R, Carver PL.
    Pharmacotherapy; 2015 Feb 15; 35(2):119-26. PubMed ID: 25689243
    [Abstract] [Full Text] [Related]

  • 39. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J.
    Clin Infect Dis; 2008 May 15; 46(10):1493-8. PubMed ID: 18419481
    [Abstract] [Full Text] [Related]

  • 40. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    Ochsner UA, Bell SJ, O'Leary AL, Hoang T, Stone KC, Young CL, Critchley IA, Janjic N.
    J Antimicrob Chemother; 2009 May 15; 63(5):964-71. PubMed ID: 19251726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.